*Correspondence: Giulio Bonomo, [email protected] These authors have contributed equally to this work ORCID: Giulio Bonomo, orcid.org/0000-0002-4749-7929 This article was submitted to Neuro-Oncology and Neurosurgical Oncology, a section of the journal Frontiers in Oncology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
If we ensure equitable access along with responsible use, this can truly change how we manage diabetes and obesity," Dr Koul added
GLP-1 receptor agonists are among the most effective weight management therapies available, offering substantial reductions in body weight along with improvements in metabolic and cardiovascular health markers
La evaluacin sistemtica de estos factores permite implementar intervenciones especficas para mejorar la respuesta teraputica
Liraglutide received NICE approval (TA664) in 2020 for use through specialist weight management services, but the criteria are narrow, and availability has been limited in practice
This reflects a fundamental reality